Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
- Conditions
- Primary Peritoneal CancerFallopian Tube CancerOvarian Cancer
- Interventions
- Behavioral: semi-structured interviews
- Registration Number
- NCT02928549
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to explore the experiences of Black women who receive care for ovarian cancer at Memorial Sloan Kettering Cancer Center, or "MSK" for short. The study consists of interviews with Black women who recently obtained some part of their ovarian cancer care at MSK.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 24
- Participant must have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer and treated by an MSK physician.
- Participants must be able to provide verbal informed consent.
- Participants must be 18 years of age or older.
- Participants must self-identify as Black/African American.
- Participant must be able to understand and speak in English
- Inability or refusal to identify race/ethnicity.
- Presence or development of a physical, cognitive or psychiatric deficit resulting in an inability to provide meaningful informed consent or to understand the study or complete the interview.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Black Women with Cancer semi-structured interviews In this formative qualitative research study we aim to use one-on-one semi-structured interviews with Black women diagnosed with ovarian cancer to learn about their experiences and their journey to accessing care at a high-volume ovarian cancer care center (HVC).
- Primary Outcome Measures
Name Time Method accessing care 1 year The study team will review and code the interview transcripts through a process of independent and collaborative thematic content analysis,\[15-18\] using ATLAS.ti (a qualitative data analysis software package) to facilitate the analysis process.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Memorial Sloan-Kettering Cancer Center
🇺🇸New York, New York, United States